Patrick Cox has lived deep inside transformative technologies for over 25 years. In the 1980s, he worked in software development and manufacturing. By the mid-‘90s, he consulted for Netscape–which handled 90% of all Internet browsing traffic at the time. InfoWorld and USA Today have featured his research, and he’s written for The Wall Street Journal, Los Angeles Times, USA Today and Reason Magazine. Patrick has appeared on Crossfire and Nightline, and been written up in The Baltimore Sun and CNBC Magazine. Now, Patrick edits Breakthrough Technology Alert and Technology Profits Confidential, uncovering transformational technologies that offer exponential gains.
Massachusetts and the Macro Picture
I'm not going to talk today to you about technology directly. Rather, I want to recognize some of the big macro economic events that took place in the last week or so -- because they will have such an enormous impact on technology. Fortunately, the bottom line is very good.
As Promised, RNAi Surges
What extraordinary days these are. I'll touch on just a few of the recent stories that have riveted me, the first of which positively pushed our portfolio...
BioTechs Moving as Technology Advances Rapidly
A lot of analysts are talking about BioTech's sterling performance compared with the rest of the market. I have a few items of news, most taken from recent press releases, regarding some of our biotechs. Then, if you're interested, I'll talk big picture for a while.
Breakthroughs in Viral Medicine Will Make Early Investors Rich
I said last week that I was going to give you an overview of the last decade's greatest scientific breakthroughs. Once I began the process, however, it became apparent to me I'd made a mistake. Here's why...
The First of Many Christmas Presents from One of Our Portfolio Picks…
I've got a couple newsworthy portfolio updates for you. It's great news for two of our companies, check it out...
It’s Been a Good Week for Breakthrough Technologies
Two major threats to technological innovation and profits have been seriously diminished. Let's take a look at why this was a good week for breakthrough tech...
And Update on our SC Companies, Climategate Reader Mail and More…
I continue to get questions about our stem cell companies. This pleases me because it indicates that you, my readers, really do understand how important regenerative medicine is. I feared I was spending too much time on the subject, but will update again today. Let's get started...
Climategate Update: Science Hasn’t Failed, Government Has
What a fascinating week. The leaked e-mails and computer code from the University of East Anglia's Climatic Research Unit have become the greatest scientific scandal of our age. This is a great case study on how government fails and science prevails...
The Importance of IP – 3 Companies that will add to Your Wealth and Health
This week, I'm going to go over the same subjects I covered last week. One reason is that seasonal allergies had me in a serious fog and I didn't do an acceptable job of covering some extremely important issues. Here's what you need to know...
Keep Your Eye on the Science — Not the Whims of the Market…
Holy Toledo. These last few weeks have been breathtaking. Not only has there been critical progress in stem cell science and virology -- there's been much, much more...